Sulfonylhydrazide compounds for treating proliferative disorders
US8680100B2 · kind B2 · utility
2Cited by
20References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 1, 2009 |
| Grant date | Mar 25, 2014 |
| Priority date | — |
| Expiry date | Dec 1, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention is directed to compounds represented by structural formula (I), or a pharmaceutically acceptable salt or a transition metal chelate, coordinate or complex thereof or a transition metal chelate, coordinate or complex of a deprotonated form of the compound. Pharmaceutical composition and method of use for these compounds are also included.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.